Trial of ketorolac/phenylephrine in paediatric patients undergoing primary cataract extraction (Europe)
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2016
Price : $35 *
At a glance
- Drugs Ketorolac/phenylephrine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Omeros Corporation
- 29 Jun 2016 Status changed from completed to active, no longer recruiting, according to an Omeros Corporation media release.
- 11 Aug 2014 Omeros Corporation expects first patient enrolment in this trial at the end of the third quarter of 2014.
- 16 Oct 2013 New trial record